Compare The United Laboratories International Holdings Ltd. with Similar Stocks
Dashboard
1
Strong Long Term Fundamental Strength with an average Return on Equity (ROE) of 15.26%
- Healthy long term growth as Operating profit has grown by an annual rate 23.13%
- Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 35.84
2
Positive results in Jun 25
3
With ROE of 18.40%, it has a Very Attractive valuation with a 1.82 Price to Book Value
4
Company is among the highest 1% of companies rated by MarketsMojo across all 4,000 stocks
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-10.14%
0%
-10.14%
6 Months
-29.5%
0%
-29.5%
1 Year
-26.09%
0%
-26.09%
2 Years
10.14%
0%
10.14%
3 Years
93.04%
0%
93.04%
4 Years
155.21%
0%
155.21%
5 Years
82.04%
0%
82.04%
The United Laboratories International Holdings Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
9.79%
EBIT Growth (5y)
23.13%
EBIT to Interest (avg)
35.84
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.29
Sales to Capital Employed (avg)
0.86
Tax Ratio
19.19%
Dividend Payout Ratio
38.70%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
24.45%
ROE (avg)
15.26%
Valuation key factors
Factor
Value
P/E Ratio
10
Industry P/E
Price to Book Value
1.82
EV to EBIT
7.57
EV to EBITDA
6.22
EV to Capital Employed
2.16
EV to Sales
1.57
PEG Ratio
NA
Dividend Yield
114.94%
ROCE (Latest)
28.56%
ROE (Latest)
18.40%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
14,917.80
15,182.50
-1.74%
Operating Profit (PBDIT) excl Other Income
3,757.60
4,156.50
-9.60%
Interest
37.90
73.90
-48.71%
Exceptional Items
74.50
-60.00
224.17%
Consolidate Net Profit
2,881.70
2,984.40
-3.44%
Operating Profit Margin (Excl OI)
207.10%
232.60%
-2.55%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is -1.74% vs 15.19% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is -3.44% vs 62.33% in Dec 2023
About The United Laboratories International Holdings Ltd. 
The United Laboratories International Holdings Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






